Lonza & Moderna partner to produce COVID-19 vaccine
Share this article
Lonza | A key player in the COVID-19 vaccine production
While the trials still prove to be successful, Lonza has confirmed its ability to produce hundreds of millions of doses as of this year. Results of phase I clinical trial are promising although they need to be evaluated cautiously. Lonza’s support helps Moderna guarantee the provision of vaccines once the serum has been validated.